Singapore markets open in 2 hours

Athira Pharma, Inc. (ATHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.9600-0.0800 (-3.92%)
At close: 04:00PM EDT
1.9800 +0.02 (+1.02%)
After hours: 05:41PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.0400
Open2.0566
Bid1.9000 x 100
Ask1.9700 x 300
Day's range1.9500 - 2.0566
52-week range1.3300 - 4.2980
Volume257,430
Avg. volume351,786
Market cap75.12M
Beta (5Y monthly)2.78
PE ratio (TTM)N/A
EPS (TTM)-3.0900
Earnings date09 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est7.42
  • GlobeNewswire

    Athira Pharma to Participate in Upcoming May Conferences

    BOTHELL, Wash., May 02, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that Company management will participate in the following upcoming investor conferences in May. Sidoti May 2024 Virtual Investor ConferenceFormat: Company PresentationDate and Time: Wednesday, May 8, 2024, from 10:45 a.m. - 11:15 a.m. ET Location: Virtual Th

  • Simply Wall St.

    One Athira Pharma Insider Raised Their Stake In The Previous Year

    Viewing insider transactions for Athira Pharma, Inc.'s ( NASDAQ:ATHA ) over the last year, we see that insiders were...

  • GlobeNewswire

    Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer

    Experienced clinical development leader with a strong track record of advancing therapeutics from early development to approval and commercializationBOTHELL, Wash., April 15, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced the appointment of Javier San Martin, M.D., as Chief Medical Officer. Dr. San Martin brings more than 25 ye